Nutraplus India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/02/2026 ,inter alia, to consider and approve 1.To consider & approve Un-audited ....
Awaiting price reaction for this filing.
Nutraplus India Limited has informed the BSE that a meeting of its Board of Directors is scheduled for 10th February 2026 at 3:00 p.m. at the registered office in Mumbai. The main agenda is to consider and approve the Un-audited Standalone Financial Results of the Company for the quarter and nine months ended 31st December 2025, along with the Limited Review Report from the auditors. Any other matters may be taken up with the Chairman's permission. The filing also notes that the trading window for dealing in the company's securities is already closed since 1st January 2026 and will remain closed until 48 hours after the results are announced.
This is a routine pre-results intimation and does not by itself move the stock. Investors should watch the actual Q3 FY26 numbers on 10th February for any signals on revenue, profitability, or margin trends. The closed trading window means insiders cannot trade until the results are made public.